Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
23 hedge funds and large institutions have $825K invested in Nymox Pharmaceutical Corp in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
10% more funds holding
Funds holding: 21 → 23 (+2)
0% more call options, than puts
Call options by funds: $4K | Put options by funds: $4K
1.99% less ownership
Funds ownership: 3.22% → 1.23% (-2%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
91% less capital invested
Capital invested by funds: $9.3M → $825K (-$8.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
WMS Partners
Towson,
Maryland
|
+$92.1K |
| 2 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$75.8K |
| 3 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
+$62K |
| 4 |
WB
Webster Bank
Waterbury,
Connecticut
|
+$27.9K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$14.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$8.91M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$26K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$14.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.6K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$11.2K |
NYMX Hedge Fund Activity: Q2 2015 in Review
23 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2015, worth a combined $825K — down 91% from $9.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NYMX positions and 4 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was WMS Partners, opening a new position worth an estimated $92.1K. The largest seller was Advisors Asset Management, exiting entirely with an estimated $8.91M sold.
- 23 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2015, up from 21 in Q1 2015.
- Funds reported $825K of Nymox Pharmaceutical Corp stock for Q2 2015, down 91% quarter-over-quarter.
- 6 funds opened new Nymox Pharmaceutical Corp positions in Q2 2015 and 4 closed out, a net change of +2 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q2 2015 was WMS Partners, an estimated $92.1K added.
- The largest Nymox Pharmaceutical Corp seller in Q2 2015 was Advisors Asset Management, an estimated $8.91M sold.
Based on aggregated 13F filings for Q2 2015.